Authorizations During Emergencies
Pfizer and BioNTech will submit an emergency use authorization request for their jointly-developed COVID-19 vaccine
Hugo Chavez Returns, Trump Goes There, And Steve Mnuchin Wants His Money Back
I hoped it wouldn’t come to this, but I can’t say I’m surprised. On Friday,
Non Sequiturs & Nonsense
I suppose I was wrong to say, on Thursday morning, that “analysts and economists are
King Dollar Relinquishes Global Payments Crown. But Save Your ‘Demise’ Narratives
Those who love a good “dethroning King Dollar” story will be excited to know that
Don’t Worry: The Housing Bubble Is Alive And Well
At least the housing bubble is intact. Existing home sales defied expectations for a decline,
Jobless Claims Unexpectedly Rise, Adding To Economic Consternation
742,000 Americans filed for unemployment claims last week, more than the market expected. It’s an
Erdogan Lets New Central Bank Governor Hike Rates. U-Turn ‘Obviously’ Won’t Last
Warm congratulations to Naci Agbal, who replaced Murat Uysal at the helm of Turkey’s central
Slow Bleed
The dollar moved higher from a 29-month low Thursday, as risk-off vibes tied to America’s
Here And Now
Stop me if you’ve heard this one before: US equities were torn between encouraging vaccine
Obligations Of The Undead
Meanwhile, from the world of “zombies” and possibly unsustainable debt burdens… The financial media (and
With Bitcoin 10 Times More Precious Than Gold, Ray Dalio Wonders If He’s ‘Missing Something’
“Investors” are flocking to Bitcoin as fears of currency debasement grow. That’s this week’s cryptocurrency
Vaccine Trade Bandwagon Jumpers Should Be Wary Of Calling Top On Tech Bubble
As the encouraging vaccine news piles up, one imagines the calls for a sustainable rotation
95% (And A Stocking Stuffer Idea)
Pfizer on Wednesday said its COVID-19 vaccine, jointly developed with BioNTech, is 95% effective according
Turmoil And Tinfoil
[Read more from NOTES FROM DISGRACELAND and follow on Twitter] 17.XI 2020 Woke up this
No, ‘Seriously’
Donald Trump was in the news Tuesday for all the usual reasons — plus a
The Vagaries Of Being Walmart In A Pandemic
Walmart, a company which knows a thing or two about the retail business, didn’t have
Macro Tourist: I’m Shorting Tesla On The Index Inclusion News
“Well, it finally happened.”
Market Close To ‘Full Bull,’ BofA Says
We’re close to “full bull,” BofA’s Michael Hartnett declared, in the latest edition of the
Retail Sales Stumbled In October, Which Isn’t Surprising Because People Are, You Know, Starving
Some will call it inevitable. US retail sales rose just 0.3% in October, less than
Nomura’s McElligott: Investors ‘Respect’ Potential For More Shocks. Complacency Not Currently An Issue
While the global equity rally looked poised to cool in the face of new virus
Pay No Attention To That Flaming Country
The latest wave of vaccine optimism receded a bit on Tuesday as the reality of
Diminishing Returns And WAM Chatter Galore
As expected, Monday’s encouraging vaccine news from Moderna prompted outperformance from value, small-caps, and other
Goldman On The Dollar: Depreciation To Extend Into 2021 – And ‘Possibly Well Beyond’
The broad, trade-weighted dollar will decline 6% over the next 12 months, Goldman says, in
Morgan Stanley: ‘Keep The Faith’ After ‘Super-Charged’ Global Economic ‘Take-Off’
“Keep the faith, trust the recovery” and buy stocks. That, in a nutshell, is the
Vaccine Push Faces Test In America, Where ‘Freedom’ Is ‘The Gateway Drug To Pseudoscience’
Over the weekend, Ron Klain, incoming White House chief of staff, underscored a crucial point
Rotation On? Moderna Vaccine News May Presage Encore For Historic Factor Reversal
The reaction to Moderna’s encouraging COVID-19 vaccine data, released exactly a week after a similarly
‘A Pivotal Moment’
Global equities found quite a bit to like in trade news and economic data out
You must be logged in to post a comment.